{"disease":{"id":"ebola-viral-disease","name":"ebola viral disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02416453","title":"A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":423,"lead_sponsor_name":"Janssen Vaccines & Prevention B.V.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}